{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:46:14Z","timestamp":1792417574543,"version":"4.4.0"},"reference-count":18,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"abstract":"<jats:p>Introduction: dans le cadre de la triple \u00e9limination du VIH, des virus de l'h\u00e9patite B et C, une meilleure compr\u00e9hension du fardeau local de ces infections est essentielle pour orienter les interventions cibl\u00e9es. Cette \u00e9tude vise \u00e0 d\u00e9terminer le profil \u00e9pid\u00e9miologique du VIH, des h\u00e9patites virales B (VHB) et C (VHC) dans le d\u00e9partement du Mayo-Tsanaga \u00e0 l'Extr\u00eame-Nord du Cameroun.\n\n \n\nM\u00e9thodes: \u00e9tude transversale de surveillance \u00e9pid\u00e9miologique r\u00e9alis\u00e9e du 1er ao\u00fbt au 20 septembre 2024. Un \u00e9chantillonnage cons\u00e9cutif a \u00e9t\u00e9 effectu\u00e9. Apr\u00e8s obtention du consentement \u00e9clair\u00e9, chaque participant a rempli un questionnaire standardis\u00e9 et a \u00e9t\u00e9 test\u00e9 pour le VIH, le VHB et le VHC selon l'algorithme national. Les donn\u00e9es ont \u00e9t\u00e9 analys\u00e9es avec Excel 2019 et Power BI, avec un seuil de significativit\u00e9 p&lt;0,05.\n\n \n\nR\u00e9sultats: au total, 3188 participants (60% de femmes, \u00e2ge m\u00e9dian 34 ans [IQR 20-46]) ont \u00e9t\u00e9 inclus. Parmi eux, 396 (12,4%) ont \u00e9t\u00e9 test\u00e9s positifs \u00e0 au moins une infection: VIH 0,41% (n = 13), VHB 11,7% (n = 373), VHC 0,31% (n = 10). Pour le VIH, une majorit\u00e9 de femmes (77%), concentr\u00e9e dans la tranche de 25-34 ans. Pour le VHB, on avait une positivit\u00e9 \u00e9lev\u00e9e au-del\u00e0 de 55 ans (27%), femmes 63,6%, pas de diff\u00e9rence significative selon le sexe (p = 0,138). Pour le VHC, on avait une distribution homog\u00e8ne, sans diff\u00e9rence significative selon \u00e2ge ou sexe.\n\n \n\nConclusion: nos r\u00e9sultats sugg\u00e8rent une possible transition vers l'\u00e9limination du VIH et du VHC dans cette population au vu de leur faible s\u00e9ropositivit\u00e9. En revanche, la forte positivit\u00e9 du VHB appelle \u00e0 renforcer la strat\u00e9gie vaccinale coupl\u00e9e au d\u00e9pistage et \u00e0 la sensibilisation ciblant prioritairement les jeunes.<\/jats:p>","DOI":"10.11604\/pamj.2026.53.45.46297","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:46:10Z","timestamp":1778849170000},"source":"Crossref","is-referenced-by-count":0,"title":["\u00c9pid\u00e9miologie des infections \u00e0 VIH, h\u00e9patites B et C et interventions prioritaires pour l'\u00e9limination de l'h\u00e9patite B: investigation dans l'Extr\u00eame-Nord du Cameroun"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-2763","authenticated-orcid":false,"given":"Joseph","family":"Fokam","sequence":"first","affiliation":[{"name":"Central Technical Group, National Aids Control Committee, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristide","family":"Dama","sequence":"additional","affiliation":[{"name":"Regional Technical Group, National Aids Control Committee, Far-North Regional Delegation of Public Health, Maroua, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Yaba","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Drug and Laboratories, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toussaint","family":"Malama","sequence":"additional","affiliation":[{"name":"Global Funds and Partners Grants Coordination Unit, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tjek","sequence":"additional","affiliation":[{"name":"Department of Family Health, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle Nounouce","family":"Bouba Pamen","sequence":"additional","affiliation":[{"name":"Central Administration, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane","family":"Diaby","sequence":"additional","affiliation":[{"name":"Central Administration, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5361-5063","authenticated-orcid":false,"given":"Rogers","family":"Ajeh Awoh","sequence":"additional","affiliation":[{"name":"University of Buea Faculty of Health Sciences and Chantal Biya International Reference Centre for Research on HIV\/AIDS Prevention and Management, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malachie","family":"Manaouda","sequence":"additional","affiliation":[{"name":"Central Administration, Ministry of Public Health, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"ref0","unstructured":"Organisation Mondiale de la Sant\u00e9. VIH et sida. Organisation mondiale de la Sant\u00e9. G\u00e9n\u00e8ve, 2022. Consult\u00e9 le 13 octobre 2024."},{"key":"ref1","unstructured":"UNAIDS. Fiche d'information - Derni\u00e8res statistiques sur l'\u00e9tat de l'\u00e9pid\u00e9mie de sida. ONUSIDA, G\u00e9n\u00e8ve, 2024. Consult\u00e9 le 13 octobre 2024."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Keugoung B, Ymele FF, Mabou JD, Nangue C, Kougoum PN, Takoudjou L et al. Financement d'une campagne de soins gratuits par une association dans un district rural au Cameroun N\u00e9cessit\u00e9 d'optimiser le r\u00f4le de la soci\u00e9t\u00e9 civile en Afrique subsaharienne. Med Sante Trop. 2013 May 1;23(2):222-4. French. PubMed","DOI":"10.1684\/mst.2013.0175"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ondigui JLN, Kenmoe S, Kengne-Nd\u00e9 C, Ebogo-Belobo JT, Takuissu GR, Kenfack-Momo R et al. Epidemiology of occult hepatitis B and C in Africa: A systematic review and meta-analysis. J Infect Public Health. 2022 Dec;15(12):1436-1445. PubMed | Google Scholar","DOI":"10.1016\/j.jiph.2022.11.008"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Taverne B, Desclaux A, Delaporte E, Ndoye I, Coll Seck AM, Barr\u00e9-Sinoussi F. Universal health coverage and HIV in resource-constrained countries: a critical juncture for research and action. AIDS. 2013 Sep 10;27(14):2173-5. PubMed | Google Scholar","DOI":"10.1097\/QAD.0b013e3283611a0e"},{"key":"ref5","unstructured":"UNAIDS. Comprendre les mesures des progr\u00e8s r\u00e9alis\u00e9s pour atteindre les objectifs 95-95-95 en mati\u00e8re de d\u00e9pistage, de traitement et de suppression virale du VIH. ONUSIDA, G\u00e9n\u00e8ve, 2024. Consult\u00e9 le 10 septembre 2024."},{"key":"ref6","unstructured":"OMS. Journ\u00e9e mondiale contre l'h\u00e9patite 2022: des soins anti-h\u00e9patite de plus grande proximit\u00e9. Organisation mondiale de la Sant\u00e9, G\u00e9n\u00e8ve, 2022. Consult\u00e9 le 25 ao\u00fbt 2025."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ngangue PA, Gagnon MP, Bedard E. Return for HIV test results after voluntary screening in Cameroon. Sant\u00e9 Publique. 2016 May-Jun;28(3):409-16. PubMed | Google Scholar","DOI":"10.1155\/2016\/9720148"},{"key":"ref8","unstructured":"Minist\u00e8re de la Sant\u00e9, Division de la Recherche Op\u00e9rationnelle en Sant\u00e9 (DROS), Comit\u00e9 National de Lutte contre le Sida (CNLS), Institut National de la Statistique (INS), Le Plan d'urgence du Pr\u00e9sident des \u00c9tats-Unis pour la lutte contre le SIDA (PEPFAR), Les centres des \u00c9tats-Unis pour le contr\u00f4le et la pr\u00e9vention des maladies (CDC), ICAP de l'Universit\u00e9 de Columbia. Evaluation de l'impact du VIH sur la Population au Cameroun CAMPHIA 2017-2018. Rapport final d\u00e9cembre 2020. Consult\u00e9 le 13 octobre 2024."},{"key":"ref9","unstructured":"ONUSIDA. Rapport mondial actualis\u00e9 sur le sida. ONUSIDA, G\u00e9n\u00e8ve, 2022. Consult\u00e9 le 13 octobre 2024."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Bigna JJ, Amougou MA, Asangbeh SL, Kenne AM, Noumegni SRN, Ngo-Malabo ET et al. Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis. BMJ Open. 2017 Jun 30;7(6):e015298. PubMed | Google Scholar","DOI":"10.1136\/bmjopen-2016-015298"},{"key":"ref11","unstructured":"Hamadou NHM, Njoya O, Kowo MP, Ankouane F, Talla P, Babagna ID et al. Traitement de l'H\u00e9patite C de G\u00e9notype 1 par les Antiviraux d'Action Directe au Cameroun: R\u00e9sultats Pr\u00e9liminaires. Health Sci Dis. 2018;19:3. Google Scholar"},{"key":"ref12","unstructured":"Comit\u00e9 National de Lutte contre le Sida. Plan Strat\u00e9gie National de lutte contre le VIH, Sida et les IST. Comit\u00e9 National de Lutte contre le Sida, septembre 2023. Consult\u00e9 le 16 f\u00e9vrier 2025."},{"key":"ref13","unstructured":"Essi MJ, Mamouda MN, Nguizaye L, Ondoua R, Hopp E, Penda R et al. Comp\u00e9tences de Sant\u00e9 Vis-\u00e0-vis de l'H\u00e9patite Virale B dans les Camps de R\u00e9fugi\u00e9s au Cameroun. Health Sci Dis. 2018;19(3 (S). Google Scholar"},{"key":"ref14","unstructured":"Kowo MP, Ngankhou\u00e9 OM, Ankouane F, Ndam AN, Talla P, Ouamba PG et al. Profil \u00c9pid\u00e9miologique des Personnes R\u00e9cemment Infect\u00e9es par le Virus de l'H\u00e9patite C au Cameroun. Health Sci Dis. 2018;19(3 (S)). Google Scholar"},{"key":"ref15","unstructured":"World Health Organization. Global hepatitis report 2017. World Health Organization. 2017."},{"key":"ref16","unstructured":"OMS. L'OMS en Afrique: 91 millions d'Africains infect\u00e9s par l'h\u00e9patite B ou C. OMS. Bureau r\u00e9gional pour l'Afrique. OMS. 2024."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Bigna JJ, Nkeck JR, Ngouo A, Nyaga UF, Noubiap JJ. Hepatitis B virus and HIV coinfection among adults residing in Cameroon: A systematic review and meta-analysis of prevalence studies. Infect Dis Health. 2018 Sep;23(3):170-178. Epub 2018 Aug 11. PubMed | Google Scholar","DOI":"10.1016\/j.idh.2018.02.006"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:08:27Z","timestamp":1792415307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/53\/45\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":18,"URL":"https:\/\/doi.org\/10.11604\/pamj.2026.53.45.46297","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}